Reuters
@Reuters·4.2M subscribers·86.9K videos
Market Insight: Roche shares on the rise after obesity drug trial results | REUTERS
Posted
May 16, 2024
Views
437
Likes
6
Engagement
1.37%
May 16, 2024
437
6
1.37%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
4:34Now PlayingThe Swiss drugmaker Roche’s race to join the likes of Novo Nordisk and Eli Lilly in the booming obesity treatment market appears to be taking shape. Roche said its weight-loss drug delivered almost 19% weight loss in early trials. Swetha Ramachandran from Artemis gave her verdict on whether it can compete effectively in this space.
#News #obesitymedicine #treatment #Reuters #Newsfeed
Read the story here:
👉 Subscribe
Keep up with the latest news from around the world
Follow Reuters on Facebook
Follow Reuters on Twitter
Follow Reuters on Instagram
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
